smallTalk (Healthcare Technology Systems) key facts
as of Oct 2026- Developer of a medical device designed to improve brain development in preterm infants.
- smallTalk (Healthcare Technology Systems) is valued at approximately $6.5M as of Oct 2026 (last reported valuation).
- It has raised $2.6M; the latest was Seed Round ($990K) in Jul 2025.
- Notable investors include Techstars, gBETA, Rev1 Ventures, Nationwide Children's Hospital, Athens Ohio Investment Alliance — 13 tracked in total.
- Status: Privately Held (backing).
smallTalk (Healthcare Technology Systems)'s last reported valuation, Jul 2025. Nothing priced has surfaced since.
- ·The complete investor list: 13 names
- ·Watch smallTalk (Healthcare Technology Systems): the Monday email on marks, rounds and moves
smallTalk (Healthcare Technology Systems) funding rounds
No funding rounds for smallTalk (Healthcare Technology Systems) are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Who backs smallTalk (Healthcare Technology Systems)
13+smallTalk (Healthcare Technology Systems) valuation
smallTalk (Healthcare Technology Systems)'s last reported valuation was $6.5 million in Jul 2025. No priced round, secondary trade or fund mark has surfaced since.
smallTalk (Healthcare Technology Systems) investors
13 investors are on record for smallTalk (Healthcare Technology Systems), including Techstars, gBETA, Rev1 Ventures and Nationwide Children's Hospital.
About smallTalk (Healthcare Technology Systems)
Developer of a medical device designed to improve brain development in preterm infants. The company offers a speaker system that delivers recorded caregiver voices to infants in NICU care, enabling hospitals to support early neurological growth in vulnerable newborns.
- Sector
- Healthcare
- HQ
- Columbus, OH, United States
- Founded
- 2017
- Employees
- 7
- Website
- smalltalk.tech/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.